Water soluble cationic trans-platinum complexes which induce programmed cell death in the protozoan parasite Leishmania infantum.

[1]  M. Fuertes,et al.  Programmed cell death in trypanosomatids: a way to maximize their biological fitness? , 2004, Trends in parasitology.

[2]  M. Menéndez,et al.  Thermodynamic stability of the C-terminal domain of the human inducible heat shock protein 70. , 2004, Biochimica et biophysica acta.

[3]  J. M. Requena,et al.  Cell-cycle-dependent translation of histone mRNAs is the key control point for regulation of histone biosynthesis in Leishmania infantum. , 2004, The Biochemical journal.

[4]  V. Brabec,et al.  DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand. , 2004, Biochemical pharmacology.

[5]  B. Sikic,et al.  Pharmacokinetics and protein binding of cis-dichlorodiammine platinum (II) administered as a one hour or as a twenty hour infusion , 2004, Cancer Chemotherapy and Pharmacology.

[6]  V. Brabec,et al.  Activation of Trans Geometry in Bifunctional Mononuclear Platinum Complexes by a Piperidine Ligand , 2003, Journal of Biological Chemistry.

[7]  S. Croft,et al.  Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. , 2003, Trends in parasitology.

[8]  V. Brabec,et al.  DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines. , 2003, Biochemistry.

[9]  H. P. Ostendorff,et al.  Orchestrating nuclear functions: ubiquitin sets the rhythm. , 2003, Trends in biochemical sciences.

[10]  L. Kèlland,et al.  Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)]. , 2003, Molecular pharmacology.

[11]  M. Fuertes,et al.  Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. , 2003, Chemical reviews.

[12]  J. Perez,et al.  Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. , 2003, Current medicinal chemistry.

[13]  M. Fernandez-Mestre,et al.  Design of copper DNA intercalators with leishmanicidal activity , 2003, JBIC Journal of Biological Inorganic Chemistry.

[14]  D. Gibson,et al.  Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines. , 2002, Journal of medicinal chemistry.

[15]  D. Gibson,et al.  Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles. , 2002, Journal of inorganic biochemistry.

[16]  J. Perez,et al.  Novel concepts in the development of platinum antitumor drugs. , 2002, Current medicinal chemistry. Anti-cancer agents.

[17]  M. Fuertes,et al.  Apoptosis Induction and DNA Interstrand Cross‐Link Formation by Cytotoxic trans‐[PtCl2(NH(CH3)2)(NHCH(CH3)2)]: Cross‐Linking between d(G) and Complementary d(C) within Oligonucleotide Duplexes , 2002, Chembiochem : a European journal of chemical biology.

[18]  N. Farrell,et al.  Ligand effects on the binding of cis- and trans-[PtCl2Am1Am2] to proteins , 2002, JBIC Journal of Biological Inorganic Chemistry.

[19]  L. Neckers,et al.  Effect of the proteasome inhibitor ALLnL on cisplatin sensitivity in human ovarian tumor cells. , 2001, International journal of oncology.

[20]  J. Perez,et al.  Current status of the development of trans-platinum antitumor drugs. , 2000, Critical reviews in oncology/hematology.

[21]  D. Wolters,et al.  κ2N(imidazole), S(thioether) Macrochelation of [Pt(en)]2+ (en = H2NCH2CH2NH2) by terminal histidine and methionine side-chains in tri-, tetra- and penta-peptides , 1999 .

[22]  J. M. Requena,et al.  Multicomponent Chimeric Antigen for Serodiagnosis of Canine Visceral Leishmaniasis , 1998, Journal of Clinical Microbiology.

[23]  T. Appleton.  Donor atom preferences in complexes of platinum and palladium with amino acids and related molecules , 1997 .

[24]  D. Craciunescu,et al.  In vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine , 1997, Parasitology Research.

[25]  E. Espinosa,et al.  Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. , 1995, Lung cancer.

[26]  J. Wilson,et al.  Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck. , 1990, British journal of clinical pharmacology.

[27]  V. Brabec,et al.  Biophysical studies of the modification of DNA by antitumour platinum coordination complexes. , 1990, Biophysical chemistry.

[28]  D A Scudiero,et al.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. , 1988, Cancer research.

[29]  C. Bugg,et al.  Structure of ubiquitin refined at 1.8 A resolution. , 1987, Journal of molecular biology.

[30]  S. Castanys,et al.  Antitrypanosomal action of cis-diamminedichloroplatinum (II) analogs. , 1987, The Journal of parasitology.

[31]  M. Hooper.  Chemotherapy of tropical diseases. , 1987 .

[32]  D. Craciunescu,et al.  Studies on the interaction between antitrypanosome cis-DDP analogs with DNA. , 1986, Chemico-biological interactions.

[33]  R. Lange,et al.  Clinical and pharmacological studies with cis-diamminedichloroplatinum (II). , 1973, Cancer research.

[34]  H. Brown.  Chemotherapy of Tropical Diseases , 1962 .